Aiforia launches a collaboration with Mayo Clinic to transform pathology practice with AI-powered solutions

Aiforia, a technology company providing deep learning AI software for image analysis in pathology, and Mayo Clinic announced today that they are collaborating to establish an AI-powered pathology research support architecture at the Mayo Clinic. Leveraging each other’s expertise in digital pathology and deep learning, the two aim to enable faster results and scalable studies in translational research.

Pathology is the cornerstone of healthcare, assisting in diagnostics, prognostics, and of course in translational research which takes scientific discoveries to the clinic. However, the same manual and subjective methods have been in use for the last 150 years to carry out slide evaluation. Aiforia’s deep learning AI software, Aiforia Create, transforms image-based analysis by escalating efficiency and precision beyond current capabilities.

Mayo Clinic's Department of Laboratory Medicine and Pathology will implement Aiforia’s software across multiple sites in the United States. Pathologists at different locations will be able to collaborate remotely as Aiforia’s adaptable software is cloud-based and readily deployed into Mayo Clinic’s existing IT infrastructure. The intent is to advance the seamless development and utilization of AI models by their pathologists for image analysis in different areas of research with Aiforia Create.

Designed by a team of expert pathologists and software developers and made for intuitive use by pathologists, Aiforia provides a hands-on tool for AI-assisted research across a variety of fields. No coding or prior programming experience is needed to use the Aiforia Create software. Pathologists at Mayo Clinic intend to utilize Aiforia’s software to generate AI models with reproducible results.

“We are very excited to embark on this collaboration with Mayo Clinic. By equipping one of the world’s top ranked hospitals with powerful deep learning-based software, leading pathologists can harness AI. This collaboration represents a significant milestone for Aiforia, in our ability to serve the growing demand for more efficient tools in digital pathology,” explains Jukka Tapaninen, CEO of Aiforia Technologies Plc.

About Aiforia

Aiforia equips pathologists and scientists in preclinical and clinical labs with powerful deep learning artificial intelligence software for translating images into discoveries, decisions, and diagnoses. The cloud based Aiforia products and services aim to escalate the efficiency and precision of medical image analysis beyond current capabilities, across a variety of fields from oncology to neuroscience and more. Find out more: www.aiforia.com

Further enquiries

Jukka Tapaninen, CEO, Aiforia Technologies Plc, tel. +33610416686

Veli-Matti Parkkonen, CFO, Aiforia Technologies Plc, tel. +358405009878

Certified Adviser

UB Securities Ltd, tel. +358405886769